Comparing two medicines to prevent heavy bleeding after planned cesarean
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (elective) cesarean section.
- You have at least one of the following risk factors: a larger than normal uterus (from too much amniotic fluid, a big baby, or multiple babies), a history of heavy bleeding after a previous birth, obesity with a BMI over 40, diabetes or high blood pressure on medication, or placenta previa.
- You do not have any heart valve problems, irregular heartbeat, or heart failure.
- You do not have placenta accreta (a condition where the placenta grows too deeply).
- You do not have a bleeding disorder or severe anemia (hemoglobin below 100 g/L).
- You are not allergic to oxytocin or carbetocin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to prevent heavy bleeding after a C-section. One uses a combination of three medicines, and the other uses a single medicine. The goal is to find which is safer and more effective at reducing blood loss.
This trial tests a new under-the-tongue tablet (sublingual oxytocin) to prevent heavy bleeding after childbirth. It aims to see if it works safely in healthy women having a vaginal delivery at full term.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This study looks at how well different doses of a contraction medicine work after an initial dose in women having a planned C-section. It may help find the best way to prevent bleeding after birth.
This trial tests if adding calcium changes how well a drug called carbetocin works to make the uterus contract after a planned C-section. It may help doctors prevent heavy bleeding after delivery.
This study tests if giving carbetocin with calcium helps the uterus contract better after a planned c-section. It's for women at 37+ weeks without high risk for poor uterine tone.
Hear when a new Post Partum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.